Evidence map›Paper›PMID 34453491›Full record

ArticleBrain and behavior2021

Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder.

Andrew M Fukuda, Jee Won Diane Kang, Asi Polly Gobin, Eric Tirrell, Fatih Kokdere, Linda L Carpenter

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Anhedonia: Current and future treatments.PCN reports : psychiatry and clinical neurosciences · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Anhedonia and Depressive Disorders.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Review
  19. Article
  20. Circuit-Targeted Neuromodulation for Anhedonia.Current topics in behavioral neurosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrew M FukudaButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.ORCID 0000-0002-7927-6602
Jee Won Diane KangButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.ORCID 0000-0003-2460-5955
Asi Polly GobinButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.
Eric TirrellButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.
Fatih KokdereButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.
Linda L CarpenterButler Hospital TMS Clinic and Neuromodulation Research Facility, Providence, Rhode Island, USA.ORCID 0000-0002-9651-3307
Providence College · US

Funding

Neuroimaging and Neuromodulation CoreP20GM130452 · NIGMS · BUTLER HOSPITAL (PROVIDENCE, RI) · PI GREENBERG, BENJAMIN D · 2019 to 2023
$11.3M
Promoting Research Training During Psychiatry ResidencyR25MH101076 · NIMH · BROWN UNIVERSITY · PI AUDREY TYRKA · 2013 to 2026
$2.8M
NIGMS NIH HHS P20 GM130452NIMH NIH HHS L30 MH127637NIMH NIH HHS R25 MH101076
6 · The paper itself

Abstract

backgroundAnhedonia is one of the defining features of depression but it remains difficult to target and treat. Transcranial magnetic stimulation (TMS) is a proven treatment for depression, but its effects on anhedonia and whether anhedonia can be used as a predictive biomarker of response is not well known.

methodsSnaith-Hamilton Pleasure Scale was administered to patients with depression before and after a standard course of TMS in a naturalistic outpatient setting.

results144 patients were analyzed. There was an overall significant improvement in anhedonia from pre- to post-treatment (7.69 ± 3.88 vs. 2.96 ± 3.45; p < .001). Significant correlations between improvements in anhedonia and other depressive symptoms were present (r = 0.55, p < .001). Logistic regression revealed that baseline anhedonia severity was not a significant predictor of clinical outcome.

conclusionThis is the first large, naturalistic study examining the effects of standard, non-research TMS on anhedonia. Among depressed patients, TMS resulted in significant improvements in anhedonia. Patients with severe baseline anhedonia had an equal chance of achieving clinical response/remission. Patients with anhedonia should not be excluded from treatment if they are safe for outpatient care and otherwise appropriate candidates for treatment.

Indexed as

Depressive Disorder, Treatment-ResistantMajor Depressive DisorderAnhedoniaBiomarkersHumansTranscranial Magnetic StimulationTreatment OutcomeBiomarkersanhedoniadepressionnaturalistictranscranial magnetic stimulation

Identifiers

PMID34453491
PMCPMC8442591
OpenAlexW3195046665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.